These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27288807)

  • 21. IGF-IR: a new prognostic biomarker for human glioblastoma.
    Maris C; D'Haene N; Trépant AL; Le Mercier M; Sauvage S; Allard J; Rorive S; Demetter P; Decaestecker C; Salmon I
    Br J Cancer; 2015 Sep; 113(5):729-37. PubMed ID: 26291053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y; Zhang QG; Wang XH
    Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
    Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.
    Fukushima T; Kataoka H
    Anticancer Res; 2007; 27(6A):3685-92. PubMed ID: 17970029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cripto-1 expression in glioblastoma multiforme.
    Pilgaard L; Mortensen JH; Henriksen M; Olesen P; Sørensen P; Laursen R; Vyberg M; Agger R; Zachar V; Moos T; Duroux M
    Brain Pathol; 2014 Jul; 24(4):360-70. PubMed ID: 24521322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.
    Mehrian-Shai R; Chen CD; Shi T; Horvath S; Nelson SF; Reichardt JK; Sawyers CL
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5563-8. PubMed ID: 17372210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme-a retrospective cohort study.
    Masood AB; Batool S; Bhatti SN; Ali A; Valko M; Jomova K; Kuca K
    Front Immunol; 2023; 14():1202098. PubMed ID: 37529045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer].
    Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
    Greenfield JP; Jin DK; Young LM; Christos PJ; Abrey L; Rafii S; Gutin PH
    Neurosurgery; 2009 May; 64(5):819-26; discussion 826-7. PubMed ID: 19404145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.
    de Bont JM; van Doorn J; Reddingius RE; Graat GH; Passier MM; den Boer ML; Pieters R
    Int J Cancer; 2008 Aug; 123(3):594-600. PubMed ID: 18478565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a panel of genes as a prognostic biomarker for glioblastoma.
    Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E
    EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme.
    Qian Z; Li Y; Ma J; Xue Y; Xi Y; Hong L; Dai X; Zhang Y; Ji X; Chen Y; Sheng M; Sheng Y; Yang L; Liu J; Dai X; Shi J; Xie T; Dong J
    J Neurooncol; 2018 Nov; 140(2):199-208. PubMed ID: 29995176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.
    Schiffgens S; Wilkens L; Brandes AA; Meier T; Franceschi E; Ermani M; Hartmann C; Sandalcioglu IE; Dumitru CA
    Oncotarget; 2016 Aug; 7(34):55169-55180. PubMed ID: 27409829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
    Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
    J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
    Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival.
    Katsaros D; Yu H; Levesque MA; Danese S; Genta F; Richiardi G; Fracchioli S; Khosravi MJ; Diamandi A; Gordini G; Diamandis EP; Massobrio M
    Eur J Cancer; 2001 Mar; 37(4):478-85. PubMed ID: 11267857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
    Cheng P; Ma Y; Gao Z; Duan L
    Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of components of the IGF axis in childhood acute myelogenous leukemia.
    Dawczynski K; Steinbach D; Wittig S; Pfaffendorf N; Kauf E; Zintl F
    Pediatr Blood Cancer; 2008 Jan; 50(1):24-8. PubMed ID: 17635002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.